Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study

摘要

Background: Preclinical studies suggest that beta-blockers could exhibit anticancer properties in ovarian cancer. Similar effects have also been reported in observational studies, but their results remain inconsistent and could be impaired by methodological limitations. This study aimed to investigate whether beta-blocker use is associated with improved survival in ovarian cancer patients at the Belgian population level.